COVID-19: Therapies and Vaccines

4/8/2020

webinar graphic

As the number of COVID-19 cases rises across the United States, development of, and access to, treatments and vaccines is an increasing priority across public and private sectors. Experts from NCSL, the Food and Drug Administration (FDA) and the pharmaceutical industry will discuss current treatment options, progress in developing new therapies and vaccines, partnerships, and other innovations in the pipeline to combat the novel coronavirus.VIEW WEBINAR

Moderator:
  • Laura Tobler, NCSL
Speakers:
  • Haley Nicholson, senior committee director, health and human services, NCSL’s State-Federal Affairs
  • Anand Shah, deputy commissioner, medical and scientific affairs, U.S. Food and Drug Administration
  • Brett Michelin, senior director, state government affairs, Association for Accessible Medicines
  • Ashlie Van Meter, senior director, state government affairs, Association for Accessible Medicines
  • Anne Pritchett, senior vice president, policy and research, Pharmaceutical Research and Manufacturers of America
  • Scott LaGanga, senior vice president, state advocacy, Pharmaceutical Research and Manufacturers of America
Resources: